Imaging facility develops successful radiation dose reduction program

According to an article in the November issue of the Journal of the American College of Radiology, a medical imaging facility in San Diego, Imaging Healthcare Specialists, has implemented a successful radiation dose reduction program, reducing radiation exposure by up to 90 percent in some patients.

"In the past decade, there have been unparalleled technological advances and growth in , with many lives saved and more costly and avoided. This growth in CT imaging, however, has also been accompanied by an unavoidable increase in cumulative to the public," said John O. Johnson, MD, author of the article.

At Imaging Healthcare Specialists, a highly successful program of reduction was created, and dose savings of up to 90 percent have been achieved in select patients.

"Our primary focus was to reduce radiation dose for of the chest, abdomen and pelvis because these constitute the most frequent studies in our practice and those with the highest radiation dose. Ultimately, all imaging protocols were revised," said Johnson.

The following dose reduction strategies were developed over months of careful computed tomography (CT) dose adjustment and imaging analysis:

  • Decreased Peak Kilovoltage
  • Low-dose Automatic Dose Modulation
  • Decreased Length of Coverage
  • Pitch
  • Iterative Reconstruction and Noise Reduction Software
In addition, the imaging facility focused on limiting double scans and multiphase examinations; performing low-dose follow-up CT examinations; and the use of iterative reconstruction and noise reduction software. A low-dose strategy for CT-guided biopsies was also developed.

"To implement such a program requires dedication, leadership and commitment. Key components include a lead CT physician, a lead CT technologist, a CT applications specialist, a continuous and systems in place to educate staff members and audit compliance," said Johnson.

"It is possible to perform high-quality CT at a fraction of the radiation dose previously thought possible. Using a combination of dose reduction strategies with or without iterative reconstruction, risks can be minimized, thereby ensuring the health and welfare of our patients," he said.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Survival hope for melanoma patients thanks to new vaccine

39 minutes ago

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

New clinical trial launched for advance lung cancer

4 hours ago

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

User comments